1093

HK:COM:CSPC

CSPC Pharmaceutical Group Limited

  • Stock

Last Close

5.09

25/11 06:05

Market Cap

72.52B

Beta: -

Volume Today

19.61M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
1.54B
-
1.45B
5.99%
1.48B
2.55%
1.63B
9.67%
2.08B
27.67%
2.73B
31.49%
2.79B
2.05%
2.20B
21.13%
2.17B
1.26%
2.52B
15.98%
3.16B
25.60%
average payables
1.26B
-
975.43M
22.58%
964.28M
1.14%
1.02B
6.22%
1.19B
16.49%
2.28B
91.35%
2.35B
2.80%
1.33B
43.15%
1.43B
7.33%
1.82B
26.83%
2.69B
48.25%
average receivables
-0.00
-
1.30B
273,185,654,373,561,664%
2.78B
113.16%
2.93B
5.59%
1.46B
50.28%
9.37B
-
book value per share
0.55
-
0.57
4.44%
0.64
13.25%
0.79
22.62%
1.09
38.42%
1.25
14.50%
1.54
23.20%
1.87
20.97%
2.17
16.37%
2.53
16.56%
3.08
21.52%
capex per share
-0.05
-
-0.06
21.08%
-0.06
6.92%
-0.09
51.34%
-0.09
6.10%
-0.18
108.13%
-0.18
2.10%
-0.13
25.72%
-0.15
11.54%
-0.23
55.31%
capex to depreciation
-0.99
-
-1.33
35.16%
-1.37
2.95%
-2.02
47.03%
-1.70
15.65%
-3.32
94.88%
-3.07
7.48%
-1.95
36.49%
-2.03
4.23%
-2.60
27.87%
capex to operating cash flow
-0.79
-
-0.45
43.31%
-0.37
18.04%
-0.41
10.18%
-0.37
8.79%
-0.56
50.68%
-0.56
0.37%
-0.23
58.30%
-0.38
62.12%
-0.36
5.87%
capex to revenue
-0.07
-
-0.07
14.13%
-0.07
1.82%
-0.10
31.51%
-0.08
17.74%
-0.12
49.21%
-0.10
18.40%
-0.06
34.18%
-0.06
0.17%
-0.09
39.47%
cash per share
0.09
-
0.10
19.12%
0.17
63.93%
0.25
49.10%
0.47
85.00%
0.55
17.87%
0.50
9.73%
0.74
47.64%
0.90
21.98%
1.16
29.72%
1.21
4.30%
days of inventory on hand
99.35
-
97.39
1.97%
107.57
10.46%
116.43
8.24%
173.10
48.67%
177.50
2.54%
149.47
15.79%
108.57
27.37%
134.49
23.87%
107.43
20.12%
123.09
14.58%
days payables outstanding
67.40
-
65.25
3.18%
67.87
4.01%
73.15
7.78%
92.76
26.82%
190.82
105.71%
84.12
55.92%
72.43
13.90%
87.98
21.47%
84.52
3.93%
111.45
31.86%
days sales outstanding
108.55
-
112.79
3.90%
96.08
14.81%
116.23
-
debt to assets
0.11
-
0.10
11.26%
0.11
10.15%
0.08
29.02%
0.05
40.58%
0.00
93.23%
0.01
129.54%
0.01
47.81%
0.00
74.30%
0.01
415.21%
0.01
7.07%
debt to equity
0.18
-
0.15
15.62%
0.17
10.34%
0.11
32.74%
0.06
42.79%
0.00
92.72%
0.01
116.61%
0.01
39.61%
0.00
74.48%
0.02
433.06%
0.02
6.35%
dividend yield
0.01
-
0.01
6.66%
0.01
12.82%
0.01
11.79%
0.01
48.51%
0.01
91.70%
0.01
28.40%
0.02
92.69%
0.02
3.89%
0.02
28.50%
earnings yield
0.02
-
0.03
12.57%
0.03
18.49%
0.04
28.14%
0.02
39.23%
0.05
96.19%
0.03
29.42%
0.05
69.16%
0.06
1.97%
0.06
12.59%
0.08
20.80%
enterprise value
34.19B
-
40.19B
17.56%
46.15B
14.84%
47.45B
2.80%
96.33B
103.03%
66.33B
31.14%
111.79B
68.53%
88.10B
21.20%
92.06B
4.50%
88.01B
4.40%
73.74B
16.21%
enterprise value over ebitda
22.32
-
22.14
0.82%
19.98
9.77%
16.29
18.44%
33.36
104.75%
14.09
57.77%
20.90
48.33%
12.81
38.71%
11.98
6.44%
10.22
14.67%
8.23
19.54%
ev to operating cash flow
53.69
-
27.82
48.18%
24.49
11.97%
18.17
25.81%
35.06
92.95%
17.06
51.35%
29.54
73.22%
13.07
55.76%
19.85
51.89%
11.54
41.88%
ev to sales
4.40
-
4.59
4.33%
4.84
5.45%
4.28
11.44%
7.46
74.03%
3.59
51.82%
5.06
40.82%
3.53
30.17%
3.30
6.47%
2.84
13.89%
2.12
25.41%
free cash flow per share
0.01
-
0.07
471.03%
0.10
49.73%
0.14
29.18%
0.15
9.16%
0.14
3.14%
0.14
2.92%
0.43
210.80%
0.24
44.25%
0.41
70.92%
free cash flow yield
0.00
-
0.02
411.69%
0.03
29.06%
0.03
23.78%
0.02
44.91%
0.02
40.44%
0.01
40.93%
0.05
278.44%
0.03
47.67%
0.05
76.54%
graham net net
-0.18
-
0.03
118.04%
0.08
152.42%
0.16
95.85%
0.13
17.72%
0.04
71.08%
0.04
8.04%
0.23
549.05%
0.34
47.10%
0.42
24.27%
1.01
140.65%
graham number
0.93
-
1.07
14.55%
1.34
24.77%
1.71
28.05%
2.21
29.11%
2.75
24.47%
3.29
19.54%
4.26
29.64%
4.79
12.44%
5.40
12.72%
6.15
14.00%
income quality
0.65
-
1.11
70.57%
1.07
4.35%
1.11
3.85%
0.95
14.25%
0.98
3.67%
0.82
16.85%
1.05
28.93%
0.68
35.79%
1.01
48.55%
intangibles to total assets
0.02
-
0.02
10.46%
0.02
15.85%
0.01
19.13%
0.01
19.33%
0.04
299.20%
0.05
20.76%
0.02
56.48%
0.02
18.82%
0.05
188.50%
0.01
90.11%
interest coverage
17.97
-
30.54
69.92%
38.24
25.21%
63.88
67.08%
129.76
103.13%
52.71
59.38%
141.87
169.14%
496.26
249.80%
889.53
79.25%
303.69
65.86%
270.22
11.02%
interest debt per share
0.10
-
0.09
12.69%
0.11
24.25%
0.09
17.68%
0.07
21.54%
0.01
83.02%
0.02
49.65%
0.03
49.55%
0.01
69.08%
0.05
499.05%
0.06
13.87%
inventory turnover
3.67
-
3.75
2.01%
3.39
9.47%
3.13
7.61%
2.11
32.74%
2.06
2.48%
2.44
18.75%
3.36
37.68%
2.71
19.27%
3.40
25.19%
2.97
12.72%
invested capital
0.18
-
0.15
15.62%
0.17
10.34%
0.11
32.74%
0.06
42.79%
0.00
92.72%
0.01
116.61%
0.01
39.61%
0.00
74.48%
0.02
433.06%
0.02
6.35%
market cap
34.07B
-
40.38B
18.54%
46.85B
16.03%
49.32B
5.27%
99.88B
102.50%
70.59B
29.33%
115.72B
63.94%
95.04B
17.87%
101.25B
6.53%
97.72B
3.48%
86.19B
11.80%
net current asset value
1.38B
-
1.80B
30.51%
2.45B
35.55%
3.46B
41.29%
6.27B
81.37%
6.10B
2.59%
6.90B
12.99%
8.95B
29.80%
12.42B
38.77%
13.83B
11.32%
17.04B
23.25%
net debt to ebitda
0.08
-
-0.11
237.48%
-0.30
183.76%
-0.64
112.62%
-1.23
90.83%
-0.90
26.51%
-0.73
18.72%
-1.01
37.37%
-1.20
18.51%
-1.13
5.63%
-1.39
23.06%
net income per share
0.07
-
0.09
25.63%
0.12
37.46%
0.16
33.73%
0.20
20.42%
0.27
35.31%
0.31
15.99%
0.43
38.93%
0.47
8.64%
0.51
9.01%
0.55
6.95%
operating cash flow per share
0.06
-
0.13
113.58%
0.17
30.45%
0.23
37.36%
0.23
2.96%
0.32
38.13%
0.32
2.46%
0.56
78.12%
0.39
31.20%
0.64
65.00%
payables turnover
5.42
-
5.59
3.29%
5.38
3.86%
4.99
7.22%
3.93
21.15%
1.91
51.39%
4.34
126.85%
5.04
16.14%
4.15
17.68%
4.32
4.09%
3.28
24.16%
receivables turnover
3.36
-
3.24
3.76%
3.80
17.39%
3.14
-
research and ddevelopement to revenue
0.08
-
0.09
20.21%
0.12
28.02%
0.12
6.32%
0.13
4.61%
0.15
19.19%
return on tangible assets
0.08
-
0.10
26.20%
0.13
20.81%
0.14
14.73%
0.13
9.87%
0.15
13.57%
0.15
0.68%
0.18
18.05%
0.16
6.37%
0.15
6.42%
0.13
16.72%
revenue per share
0.73
-
0.77
6.08%
0.84
8.90%
0.97
15.08%
1.10
14.15%
1.54
39.49%
1.85
19.98%
2.09
12.85%
2.33
11.74%
2.60
11.35%
2.93
12.76%
roe
0.13
-
0.16
20.29%
0.19
21.38%
0.21
9.06%
0.18
13.01%
0.21
18.18%
0.20
5.85%
0.23
14.84%
0.22
6.64%
0.20
6.48%
0.18
11.99%
roic
0.12
-
0.14
20.19%
0.17
18.84%
0.19
13.15%
0.17
10.53%
0.22
27.36%
0.20
8.86%
0.22
10.07%
0.22
0.38%
0.20
7.91%
0.17
14.45%
sales general and administrative to revenue
0.06
-
0.05
19.23%
0.05
6.78%
0.04
4.65%
0.04
-
0.03
8.69%
0.04
11.97%
0.04
4.43%
0.04
4.62%
shareholders equity per share
0.55
-
0.57
4.44%
0.64
13.25%
0.79
22.62%
1.09
38.42%
1.25
14.50%
1.54
23.20%
1.87
20.97%
2.17
16.37%
2.53
16.56%
3.08
21.52%
stock based compensation to revenue
0.01
-
0.00
62.34%
0.00
-
0.00
20.33%
0.00
73.91%
0.01
716.47%
tangible asset value
5.62B
-
6.27B
11.52%
7.14B
13.80%
8.95B
25.47%
12.69B
41.68%
14.08B
10.96%
18.19B
29.25%
22.44B
23.35%
26.21B
16.79%
29.50B
12.55%
38.30B
29.82%
tangible book value per share
0.53
-
0.55
4.99%
0.63
13.78%
0.78
24.38%
1.08
38.63%
1.17
8.28%
1.52
29.57%
1.88
23.36%
2.19
16.80%
2.48
12.89%
3.23
30.32%
working capital
1.98B
-
2.40B
21.27%
3.49B
45.17%
3.89B
11.54%
6.58B
69.21%
6.54B
0.56%
7.46B
14.01%
9.62B
28.94%
13.11B
36.29%
15.00B
14.41%
18.24B
21.58%

All numbers in (except ratios and percentages)